Jonsson Ove, Palma Villar Rodrigo, Nilsson Lars B, Norsten-Höög Carina, Brogren Jacob, Eriksson Marie, Königsson Kristian, Samuelsson Anders
Global DMPK Innovative Medicines, In vivo Screening & Profiling, AstraZeneca R&D, Södertälje, Sweden.
Bioanalysis. 2012 Mar;4(6):661-74. doi: 10.4155/bio.12.25.
Capillary microsampling (CMS) is a new technique for simplified collection, handling and analysis of small, exact volumes of liquid matrices. CMS was compared with conventional large volume sampling, in toxicology studies in rat and dog.
Bioanalytical validation data were well within acceptance limits. Toxicokinetic (TK) parameters from microsampling were in agreement with data from conventional volume sampling. Clinical pathology parameters in rats measured 2 days after repeated microsampling were not affected when compared with rats not sampled.
The fast collection and simple handling of small, exact volumes of liquid blood makes the CMS technique generic and flexible, as well as easily implemented and automated. Presented data support that TK measurements can be performed in main study rats, instead of dosing additional satellite animals only for TK sampling, giving both a higher scientific value and a substantial reduction of animal numbers in preclinical development.
毛细管微量采样(CMS)是一种用于简化小体积精确液体基质采集、处理和分析的新技术。在大鼠和犬的毒理学研究中,对CMS与传统大体积采样进行了比较。
生物分析验证数据完全在可接受范围内。微量采样的毒代动力学(TK)参数与传统体积采样的数据一致。与未采样的大鼠相比,重复微量采样2天后测量的大鼠临床病理学参数未受影响。
快速采集和简单处理小体积精确液体血液使CMS技术具有通用性和灵活性,易于实施和自动化。现有数据支持可以在主要研究大鼠中进行TK测量,而不是仅为TK采样额外设置卫星动物给药,这在临床前开发中既具有更高的科学价值,又能大幅减少动物数量。